CTLA4 and ovarian carcinoma: Chiappinelli et al. have reported that DNA methyltransferase inhibitors induce type I IFN signaling and apoptosis in ovarian cancer cells and sensitize them to anti CTLA4 therapy in a melanoma mouse model [13].